Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Allogenic Plasma for Ligneous Conjunctivitis
NCT05404932Recruiting
- Sponsor
- University of Saskatchewan
- Start
- Dec 2022
- Primary completion
- Sep 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in ligneous conjunctivitis, sponsored by University of Saskatchewan. Primary endpoints: Mean difference in the size of pseudomembranous conjunctival lesion at 2 months, Time to change in the size of pseudomembranous lesions by 50% or greater at 24 months and 2 more. Started Dec 2022; status: recruiting.
02
Conditions
ligneous conjunctivitis
Beyond the preview
Go deeper on NCT05404932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05404932.